Erasca (ERAS) Revenue & Revenue Breakdown
Erasca Revenue Highlights
Erasca Revenue by Period
Erasca Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Erasca Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $5.58M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Erasca Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ARVN | Arvinas | $78.50M | $76.50M |
RLAY | Relay Therapeutics | $25.55M | - |
STOK | Stoke Therapeutics | $8.78M | $4.22M |
IPSC | Century Therapeutics | $2.23M | $771.00K |
PLRX | Pliant Therapeutics | $1.58M | - |
LIFE | aTyr Pharma | $353.00K | $235.00K |
KROS | Keros Therapeutics | $151.00K | $83.00K |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
BDTX | Black Diamond Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
NGM | NGM Biopharmaceuticals | - | $165.00K |
OLMA | Olema Pharmaceuticals | - | - |
ERAS | Erasca | - | - |
MLYS | Mineralys Therapeutics | - | - |
SANA | Sana Bio | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
ZNTL | Zentalis Pharmaceuticals | - | - |
EWTX | Edgewise Therapeutics | - | - |
ERAS Revenue FAQ
What is Erasca’s yearly revenue?
Erasca's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ERAS's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Erasca’s quarterly revenue?
Erasca's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ERAS's quarterly revenue for Q4 2023 was $5.58M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Erasca’s revenue growth rate?
Erasca's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.